| |
| | Patent 5,968,913 |
 | | Novel pharmaceutical compositions of uridine 5'-triphosphate (UTP) for use in promoting increased mucociliary clearance of retained mucous secretions of the human airways, middle/inner ears or sinuses are disclosed. |
 | | Novel Formulation I comprises UTP and aqueous solution having a therapeutic concentration between 5 and 45 mg/mL, a controlled tonicity within the range of 250 to 100 mOsM, a pH between 7.0 and 7.5, and is sterile. |
 | | The compositions comprise a UTP raw material, e.g., uridine 5'-triphosphate trisodium salt dihydrate, in a sterile aqueous solution or suspension. |
| www.pharmcast.com /Patents/101999OG/5968913_uridine101999.htm (681 words) |
|